作者
Joel C Marrs
发表日期
2010/11
来源
Annals of Pharmacotherapy
卷号
44
期号
11
页码范围
1762-1769
出版商
SAGE Publications
简介
Objective
To review the pharmacology, pharmacokinetics, pharmacodynamics, efficacy data, and adverse effects of spironolactone in the treatment of resistant hypertension.
Data Sources
A literature search was conducted using MEDLINE (1966-July 2010), International Pharmaceutical Abstracts (1970-July 2010), and Cochrane database (2009) for the key words spironolactone or resistant hypertension. References cited in the articles were reviewed for additional information.
Study Selection and Data Extraction
English-language literature reporting pharmacology data from animal studies and clinical trials evaluating the pharmacology, pharmacokinetics, pharmacodynamics, efficacy data, and adverse effects of spironolactone were included.
Data Synthesis
Spironolactone is a potassium-sparing diuretic with anti-aldosterone effects that are beneficial in the management of hypertension. Spironolactone has shown …
引用总数
20112012201320142015201620172018201920202021202220236597322311
学术搜索中的文章